Over the course of the period covered by this forecast, expansion of the worldwide biotechnology market is anticipated to be driven by rising investments in the pharmaceutical industry. For example, according to the Key Data 2019 published by the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical industry in Europe invested US$ 19, 509 million in the year 2000, and this number is estimated to have climbed to US$ 39,895 million in 2018.In addition to this, the growing prevalence of chronic illnesses is also anticipated to contribute to the expansion of the market. For instance, based on the findings of a study titled "Projections of cancer prevalence in the United Kingdom, 2010-2040," which was published in the British Journal of Cancer, it is anticipated that the number of persons afflicted with cancer in the United Kingdom will rise from 2.5 million in 2015 to 4 million by the year 2030. This is a significant increase from the current rate of incidence, which stands at 2.5 million.
Biotechnology Market
The global was valued at US$ 518.3 Bn in 2019 and is forecast to reach a value of US$ 1,303.1 Bn by 2027 at a CAGR of 12.3% between 2020 and 2027.
Major Players in the Biotechnology Industry:
1. Abbott Laboratories.
Abbott Laboratories was founded in 1888 and its headquarter Chicago, Illinois, United States. The company operates in 55 countries. In2020 Abbott Laboratories has partnered biotechnology company Biocon Ltd to develop nutrition products for India
2. Amgen Inc
Amgen Inc founded in 1980, and it’s located in Thousand Oaks, California, United States. The company operates in 8 Countries. In2020 Akzo Nobel N.V. has completed the acquisition of Colombia-based paints and coatings company
